Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 47
  • Journal CiteScore: 16.17
  • Journal Impact Factor: 2.63
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +441518081309
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Abstract

MIXED IPV-OPV SCHEDULING TO HELP ERADICATE VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS

Dr Fazal-e-Rabi Subhani1*, Dr. Ahmad Ehsan Rabani2 , Dr. Fazal-i-Akbar Danish3

The In current OPV-using countries, an estimated 306-490 VAPP cases have been reported. The overall risk is about 1 case per 900,000 vaccines. This risk is exuberantly high (2 per 1000 vaccines) in individuals with B-cell immunodeficiency (OPV is thus contraindicated in immunodeficient individuals). Normal OPV recipient infants continue to shed OPV viruses for as long as 6-8 weeks after administration. In endemic places with inadequate vaccine coverage, the OPV viruses may consequently start to spread in the community.